Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

SELL
$16.06 - $26.39 $165,964 - $272,714
-10,334 Reduced 34.34%
19,760 $336,000
Q2 2022

Aug 16, 2022

BUY
$20.49 - $39.72 $79,890 - $154,868
3,899 Added 14.88%
30,094 $646,000
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $16,801 - $27,773
-596 Reduced 2.22%
26,195 $969,000
Q4 2021

Feb 09, 2022

SELL
$41.2 - $73.6 $143,582 - $256,495
-3,485 Reduced 11.51%
26,791 $1.22 Million
Q3 2021

Nov 12, 2021

SELL
$59.15 - $91.99 $56,192 - $87,390
-950 Reduced 3.04%
30,276 $1.92 Million
Q2 2021

Aug 16, 2021

BUY
$63.02 - $95.11 $1.01 Million - $1.53 Million
16,105 Added 106.51%
31,226 $2.86 Million
Q1 2021

May 14, 2021

SELL
$57.62 - $95.6 $1.01 Million - $1.68 Million
-17,546 Reduced 53.71%
15,121 $1.03 Million
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $1.13 Million - $2.1 Million
27,276 Added 505.95%
32,667 $2.37 Million
Q3 2020

Nov 12, 2020

BUY
$30.88 - $37.94 $166,474 - $204,534
5,391 New
5,391 $205,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.